Research Advancements of GABAB Receptors in Diseases of Central Nervous System

Neural Injury and Functional Reconstruction ›› 2023, Vol. 18 ›› Issue (9) : 526-529.

PDF(896 KB)
中国科技核心期刊
美国《化学文摘》CAS数据库收录
日本科学技术振兴机构数据库收录
湖北省优秀期刊
中国知网网络首发期刊
PDF(896 KB)
Neural Injury and Functional Reconstruction ›› 2023, Vol. 18 ›› Issue (9) : 526-529.
综述

Research Advancements of GABAB Receptors in Diseases of Central Nervous System

Author information +
History +

Abstract

Objective Due to the complexity of the etiology and pathogenesis, there is still no effective therapeutic strategies for diseases of the central nervous system (CNS). GABAB receptors are widely distributed in neurons and glial cells, and play important roles in the regulation of neurotransmitter release and neuronal excitability. It has been proven that GABAB receptors are involved in the development of a variety of CNS diseases, including epilepsy, depression, stroke, Alzheimer's disease, and autoimmune encephalitis. Therefore, clarifying the roles of GABAB receptors in the pathology of CNS diseases is essential for the development and clinical application of GABAB receptor-related drugs. In this paper, the specific mechanisms of GABAB receptors involved in various CNS diseases are reviewed based on the structures and functions of BABAB receptors.

Key words

γ-aminobutyric acid

Cite this article

Download Citations
Research Advancements of GABAB Receptors in Diseases of Central Nervous System[J]. Neural Injury and Functional Reconstruction. 2023, 18(9): 526-529
PDF(896 KB)

Accesses

Citation

Detail

Sections
Recommended

/